Research Calls II
- Upgrades:
- Algonquin Power & Utilities (AQN) upgraded to Outperform from Neutral at Credit Suisse; tgt $15
- Amgen (AMGN) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $279
- e.l.f. Beauty (ELF) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $46
- Getty Images (GETY) upgraded to Buy from Hold at The Benchmark Company; tgt $9
- lululemon athletica (LULU) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $350
- Seagen (SGEN) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt raised to $178
- Downgrades:
- ACM Research (ACMR) downgraded to Underperform from Buy at Jefferies; tgt $8
- Qorvo (QRVO) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $85
- Skyworks (SWKS) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $95
- SunPower (SPWR) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $18
- Vitru (VTRU) downgraded to Neutral from Buy at Goldman; tgt $22
- Zoom Video (ZM) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $90
- Others:
- Arcus Biosciences (RCUS) initiated with an Overweight at Morgan Stanley; tgt $40
- Boston Beer Co (SAM) initiated with a Neutral at Wedbush; tgt $350
- Brown-Forman (BF.A BF.B) initiated with a Neutral at Wedbush; tgt $70
- C4 Therapeutics (CCCC) initiated with an Underweight at Morgan Stanley; tgt $6
- Celanese (CE) initiated with a Neutral at Mizuho; tgt $116
- Celsius (CELH) initiated with a Neutral at Wedbush; tgt $90
- Constellation Brands (STZ) initiated with an Outperform at Wedbush; tgt $275
- CRISPR Therapeutics (CRSP) initiated with an Underweight at Morgan Stanley; tgt $37
- Cytokinetics (CYTK) initiated with a Buy at UBS; tgt $80
- Eastman Chemical (EMN) initiated with a Neutral at Mizuho; tgt $116
- Enovis Corporation (ENOV) initiated with a Buy at Goldman; tgt $57
- Intellia Therapeutics (NTLA) initiated with an Overweight at Morgan Stanley; tgt $84
- International Seaways (INSW) initiated with a Buy at Deutsche Bank; tgt $40
- Keurig Dr Pepper (KDP) initiated with an Outperform at Wedbush; tgt $43
- MGP Ingredients (MGPI) initiated with an Outperform at Wedbush; tgt $125
- Molson Coors Brewing (TAP) initiated with a Neutral at Wedbush; tgt $50
- Monster Beverage (MNST) initiated with a Neutral at Wedbush; tgt $95
- Neurocrine Biosciences (NBIX) initiated with a Buy at UBS; tgt $136
- PepsiCo (PEP) initiated with an Outperform at Wedbush; tgt $185
- POINT Biopharma (PNT) initiated with an Outperform at Oppenheimer; tgt $20
- Qualys (QLYS) initiated with a Buy at Canaccord Genuity; tgt $180
- Rani Therapeutics (RANI) initiated with a Buy at UBS; tgt $15
- Rapid7 (RPD) initiated with a Buy at Canaccord Genuity; tgt $60
- Revance Therapeutics (RVNC) initiated with an Equal-Weight at Morgan Stanley; tgt $27
- Snowflake (SNOW) initiated with a Mkt Perform at Bernstein
- Texas Instruments (TXN) initiated with a Market Perform at Cowen; tgt $170
- The Duckhorn Portfolio (NAPA) initiated with an Outperform at Wedbush; tgt $18
- United Therapeutics (UTHR) initiated with an Overweight at Morgan Stanley; tgt $288
